Product
Supplier
Encyclopedia
Inquiry
Home > News > Company Dynamic
ECHEMI chemical news

Company Dynamic

AstraZeneca Executive Suspected of Smuggling and Insurance Fraud: Multiple Cases Involving Over Millions

AstraZeneca Executive Suspected of Smuggling and Insurance Fraud: Multiple Cases Involving Over Millions

2024-12-26

On December 10, Realbio Gene Technology Co., Ltd. (688217.SH) announced that its chairman, general manager Xiong Hui, and vice general manager Xiong Jun were arrested on suspicion of fraud. Realbio’s main business involves in vitro diagnostic products and

Advancion Launches Elevance Ultra, Next-Generation Hair Fixative/Pigment Dispersant

Advancion Launches Elevance Ultra, Next-Generation Hair Fixative/Pigment Dispersant

2024-12-26

To meet global demand for high-performance, enhanced safety and sustainable ingredients, Advancion Corp. has introduced a variety of multifunctional additives for various industries based on its novel aminopentanol technology platform.

LyondellBasell and Partners Invest in Alterra’s Advanced Recycling Technology

LyondellBasell and Partners Invest in Alterra’s Advanced Recycling Technology

2024-12-26

Alterra announced the closing of the first round of its latest equity investment, with investors including Infinity Recycling, LyondellBasell and Chevron Phillips Chemical.

By-Health Faces Challenges After Thirteen Years of Growth: Revenue and Profit Down in 2024

By-Health Faces Challenges After Thirteen Years of Growth: Revenue and Profit Down in 2024

2024-12-25

Founded in 1995, By-Health introduced dietary supplements (VDS) to China in 2002 and successfully listed in 2010. Benefiting from its early investment in non-direct sales channels and leveraging the growth of chain pharmacies, the company transitioned suc

Investigation of Three Drugs for Invoice Fraud Affects Stock Market Fluctuations

Investigation of Three Drugs for Invoice Fraud Affects Stock Market Fluctuations

2024-12-25

On December 20, China’s National Healthcare Security Administration (NHSA) issued an official letter to provincial and regional healthcare bureaus, requiring an investigation into ginkgo leaf extract injection, cefotaxime sodium injection, and hydrolyzed

BASF Sells Food and Health Business to LDC

BASF Sells Food and Health Business to LDC

2024-12-25

According to a December 23 announcement on BASF’s official website, the company has signed a legally binding agreement to sell its Food and Health functional ingredients business (including the Iletten production site in Germany) to Louis Dreyfus Company

EU Initiates Anti-Dumping Investigation on Barium Carbonate from China and India

EU Initiates Anti-Dumping Investigation on Barium Carbonate from China and India

2024-12-25

Following an application submitted by Kandelium Group GmbH on November 5, 2024, the European Commission has decided to initiate an anti-dumping investigation on barium carbonate from China and India. The product falls under the EU Combined Nomenclature (C

Ineos Styrolution announces first supermarket yoghurt cups from mechanically recycled polystyrene

Ineos Styrolution announces first supermarket yoghurt cups from mechanically recycled polystyrene

2024-12-25

INEOS Styrolution, the world’s leading styrenics company, has announced the successful completion of its first mechanically recycled polystyrene yoghurt cup project.

AbbVie Acquires Nimble, Accelerating the Development of Oral Peptide Therapies

AbbVie Acquires Nimble, Accelerating the Development of Oral Peptide Therapies

2024-12-24

Oral medications are increasingly favored by long-term treatment patients due to their convenience. Current oral medications include PDE4 inhibitor apremilast, TYK2 allosteric inhibitor deucravacitinib, and JAK inhibitor upadacitinib. Moreover, numerous m

Novo Nordisk Announces 68-Week Weight Loss Data from REDEFINE 1 Clinical Trial

Novo Nordisk Announces 68-Week Weight Loss Data from REDEFINE 1 Clinical Trial

2024-12-24

Recently, Novo Nordisk announced the efficacy and safety data from its semaglutide and Cagrilintide combination therapy in the weight loss domain from the Phase III clinical trial REDEFINE 1.

Cangzhou Bohai New Area Invests 175 Million Yuan to Build 50,000 Tons Polyurea Project

Cangzhou Bohai New Area Invests 175 Million Yuan to Build 50,000 Tons Polyurea Project

2024-12-24

It has been learned that Cangzhou Bohai New Area High Cohesion Energy Chemical Co., Ltd. plans to invest 175 million yuan to initiate a new project for an annual output of 50,000 tons of polyurea (i.e., high-end polyurethane and its auxiliary materials).

Mitsubishi Chemical Group Expands Synthetic Silicon Powder Production Capacity

Mitsubishi Chemical Group Expands Synthetic Silicon Powder Production Capacity

2024-12-24

Mitsubishi Chemical Group (MCG Group) has decided to expand the production capacity of "Mitsubishi Synthetic Silicon", a synthetic silicon powder used in semiconductor manufacturing processes.

Comprehensive material upgrade! SABIC launches LNP ELCRES CXL polycarbonate copolymer resin

Comprehensive material upgrade! SABIC launches LNP ELCRES CXL polycarbonate copolymer resin

2024-12-24

Saudi Basic Industries Corporation (SABIC), a global leader in the chemical industry, has launched new LNP ELCRES CXL polycarbonate (PC) copolymer resins with excellent chemical resistance.

BASF sells food and health functional ingredients business to Louis Dreyfus Company

BASF sells food and health functional ingredients business to Louis Dreyfus Company

2024-12-24

BASF has signed a binding agreement to sell its food and health functional ingredients business, including the production site in Illertissen, Germany, to Dutch agricultural product trader and processor Louis Dreyfus Company (LDC).

Jinxing Pharmaceuticals Partners with Sanofi for Exclusive Collaboration, Accelerating Aficamten’s Entry into Chinese Market

Jinxing Pharmaceuticals Partners with Sanofi for Exclusive Collaboration, Accelerating Aficamten’s Entry into Chinese Market

2024-12-20

On December 20, Jinxing Pharmaceuticals and Sanofi officially announced a collaboration agreement, granting Sanofi exclusive rights to develop and commercialize aficamten in the Greater China region. The transaction is expected to be completed within 2024

Novo Nordisk's Expansion Triggers Labor Competition in Denmark: 32,000 Employees Increase by 75%

Novo Nordisk's Expansion Triggers Labor Competition in Denmark: 32,000 Employees Increase by 75%

2024-12-20

In recent years, the rapid expansion of Danish pharmaceutical giant Novo Nordisk has not only driven national economic growth but also sparked intense labor competition. As of September this year, Novo Nordisk has reached approximately 32,000 employees in

ADNOC Completes Acquisition of 91.3% Stake in Covestro, Transaction Valued at €12.87 Billion

ADNOC Completes Acquisition of 91.3% Stake in Covestro, Transaction Valued at €12.87 Billion

2024-12-20

On December 19, ADNOC InternationaGermany Holding AG (referred to as the “acquirer”) announced that following the end of the additionaacceptance period on December 16, 2024, it has successfully completed a voluntary public takeover offer, holding 91.3% of

Anti-Dumping Investigation on PP Homopolymer Launches in 9 Countries

Anti-Dumping Investigation on PP Homopolymer Launches in 9 Countries

2024-12-20

On December 4, 2024, relevant authorities officially announced the decision to initiate an anti-dumping investigation on PP homopolymer (PP Homopolymer). The products involved in this investigation include polypropylene, in forms such as granules, pellets

Puig and Charlotte Tilbury extend strategic partnership

Puig and Charlotte Tilbury extend strategic partnership

2024-12-20

Puig and entrepreneur Charlotte Tilbury have announced the extension of their strategic partnership in the founder’s eponymous beauty brand until the end of 2030.

Clariant achieves 100% PFAS-free additive portfolio

Clariant achieves 100% PFAS-free additive portfolio

2024-12-20

Clariant has reached an important milestone by becoming the first company in the industry to launch a completely PFAS PFAS-free additive product portfolio.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.